Neonatal hair analysis contribution to establishing a gestational drug exposure profile and predicting a withdrawal syndrome

Therapeutic Drug Monitoring

Volumn 25, Issue 4, 2003, Pages 421-432

  Vinner, Elisabeth ^a   Vignau, Jean ^b   Thibault, Denise ^b   Codaccioni, Xavier ^b   Brassart, Claudie ^a   Humbert, Luc ^a   Lhermitte, Michel ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

Cannabinoids; Cocaine; Drugs; Methadone; Opiates; Withdrawal syndrome

Indexed keywords

CANNABINOID; COCAINE; ILLICIT DRUG; METHADONE; OPIATE;

ARTICLE; DISEASE SEVERITY; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HUMAN; HUMAN CELL; IMMUNOASSAY; MASS SPECTROMETRY; MECONIUM; NEONATAL WITHDRAWAL SYNDROME; NEWBORN; PRENATAL EXPOSURE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SCREENING TEST; TOXICOLOGY; URINALYSIS; WITHDRAWAL SYNDROME;

EID: 0042768088     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200308000-00002     Document Type: Article

References (46)

1. Baumgartner AM, Jones PF, Baumgartner WA, et al. Radioimmunoassays of hair for determination of opiate-abuse histories. J Nucl Med. 1979;20:748-752.
2. Klein J, Karaskov T, Koren G. Clinical applications of hair testing for drugs of abuse. The Canadian experience. Forensic Sci Int. 2000;107:281-288.
3. Sachs H, Kintz P. Consensus of the Society of Hair Testing on hair testing for doping agents. Forensic Sci Int. 2000;107:3.
4. Ostrea EM, Welch RA. Detection of prenatal drug exposure in the pregnant women and her newborn infant. Clin Perinatol. 1991;18:629-645.
5. Kintz P, Mangin P. Determination of gestational opiate, nicotine, benzodiazepine, cocaine, and amphetamine exposure by hair analysis. Forensic Sci Soc. 1993;33:139-142.
6. Samperiz S, Millet V, Arditti J, et al. Value of toxicological research in newborn infants of addicted mothers by the study of several samples (urine, meconium, hair). Arch Pediatr. 1996:3:440-444.
7. Wennig R. Potential problems with the interpretation of hair analysis results. Forensic Sci Int. 2000;107:5-12.
8. Uhl M. Interpretation of quantitative findings and data evaluation in hair analysis. In: Müller RK, Thieme D, eds. "Progress in Hair Analysis for Illegal Drugs." 2000:61-78. Cologne, Germany. Sport und Buch Strauss. 15BN3-89001-335X.
9. Kidwell DA, Blank DL. Environmental exposure - the stumbling block of hair testing. In: Kintz P, ed. Drug Testing in Hair. Boca Raton, FL: CRC Press, 1996:17-68.
10. Harkey MR. Anatomy and physiology of hair. Forensic Sci Int. 1993;63:9-18.
11. Pötsch L. Observations about ultrastructure and chemistry of human hair. In: 2nd International Meeting on Hair Analysis, Genoa, 1994.
12. Kintz P, ed. Drug Testing in Hair. Boca Raton, FL: CRC Press, 1996.
13. Henderson GL. Mechanisms of drug incorporation into hair. Forensic Sci Int. 1993;63:19-29.
14. Cone EJ. Mechanisms of drug incorporation into hair. Ther Drug Monit. 1996;148:438-443.
15. Pötsch L, Skopp G, Moeller RM. Biochemical approach in the conservation of drug molecules during hair fiber formation. Forensic Sci Int. 1997;84:25-35.
16. Pragst F, Rothe M, Spiegel K, et al. Illegal and therapeutic drug concentrations in hair segments - A timetable of drug exposure? Forensic Sci Rev. 1998;10:81-111.
17. Cirimele V, Kintz P, Mangin P. Drug concentrations in human hair after bleaching. J Anal Toxicol. 1995;19:331-332.
18. Yegles M, Marson Y, Wennig R. Influence of bleaching on stability of benzodiazepines in hair. Forensic Sci Int. 2000;107:87-92.
19. Cone EJ, Joseph R Jr. The potential for bias in hair testing for drugs of abuse. In: Kintz P. ed. Drug Testing in Hair. Boca Raton. FL: CRC Press, 1996:69-93.
20. Kelly C, Mieczkowski T. Sweeney SA, et al. Hair analysis for drugs of abuse. Hair color and race differentials of systemic differences in drug preferences? Forensic Sci Int. 2000;107:63-86.
21. Yegles M, Dauberschmidt C, Wennig R. Comparison of different extraction procedures to detect 7-aminoflunitrazepam and nordazepam in human hair. In: AAFS Meeting. San Francisco, 1998:9-14.
22. Goulle JP, Kintz P, Lafargue P. et al. Consensus sur l'analyse des substances organiques dans les cheveux (commission « cheveux », SFTA). Toxicorama. 1994;6(2):5-8. Available at http://www.sfta.asso.fr/Toxicorama/techniques/consensus cheveux.htm.
23. Society of Hair Testing. Statement of the Society of Hair Testing concerning the examination of drugs in human hair. J Anal Toxicol. 1991;15:250-255.
24. 9-tetrahydrocannabinol, cannabinol, and cannabidiol. J Anal Toxicol. 1996;20:13-16.
25. Alburges ME, Huang W, Foltz RL, et al. Determination of methadone and its N-demethylation metabolites in biological specimens by GC-PICI-MS. J Anal Toxicol. 1996;20:362-368.
26. Subpart B. National Institute on Drug Abuse and Department of Health and Human Services. In: NIDA Guidelines. Federal Register. 1994;59(110):Sect 2.4(c,h).
27. , Kintz P, Cirimele V, Pepin G, et al. Identification et dosage des cannabinoides dans le sang total. Toxicorama. 1996:2:29-33.
28. Sachs H, Kintz P. Testing for drug in hair. Critical review of chromatographic procedures since 1992. J Chromatogr B Biomed Sci Appl. 1998;713:147-161.
29. Jurado C, Menendez M, Repetto M, et al. Hair testing for cannabis in Spain and France: is there a difference in consumption? J Anal Toxicol. 1996;20:111-115.
30. Strano-Rossi S. Chiarotti M. Solid-phase extraction for cannabinoids analysis in hair and its possible application to other drugs. J Anal Toxicol. 1999;23:7-10.
31. Gaillard Y, Pepin G, Marquet P, et al. Identification et dosage de la benzoylecgonine, cocaine, morphine et 6-MAM dans le sang total. Toxicorama. 1996;2:17-22.
32. Montagna M, Stramesi C, Vignali C, et al. Simultaneous hair testing for opiates, cocaine, and metabolites by GC-MS: a survey of applicants for driving licenses with a history of drug use. Forensic Sci Int. 2000;107:157-167.
33. Gaillard Y, Pepin G. Simultaneous solid-phase extraction on C18 cartridges of opiates and cocaine for an improved quantitation in human hair by GC-MS: one year of forensic applications. Forensic Sci Int. 1997;86:49-59.
34. Kintz P, Mangin P. What constitutes a positive result in hair analysis: proposal for the establishment of cut-off values. Forensic Sci Int. 1995;70:3-11.
35. Cone EJ, Yousefnejad D, Darwin WD, et al. Testing human hair for drugs of abuse. II. Identification of unique cocaine metabolites in hair of drug abusers and evaluation of decontamination procedures. J Anal Toxicol. 1991;15:250-255.
36. Piekoszewski W, Janowska E, Stanaszek R, et al. Determination of opiates in serum, saliva and hair addicted persons. Przegl Lek. 2001;58:287-289.
37. Kintz P, Mangin P. Determination of gestational opiate, nicotine, benzodiazepine, cocaine and amphetamine exposure by hair analysis. J Forensic Sci Soc. 1993;33:139-142.
38. Sporkert F, Pragst F. Determination of methadone and its metabolites EDDP and EMDP in human hair by headspace solid-phase microextraction and gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl. 2000;746:255-264.
39. Moeller MR, Fey P, Wennig R. Simultaneous determination of drugs of abuse (opiates, cocaine and amphetamine) in human hair by GC-MS and its application to a methadone treatment program. Forensic Sci Int. 1993;63:185-206.
40. Wilkins DG, Nagasawa PR, Gygi SP, et al. Quantitative analysis of methadone and two major metabolites in hair by positive chemical ionization ion trap mass spectrometry. J Anal Toxicol. 1996:20:355-361.
41. Forman R, Schneiderman J, Klein J, et al. Accumulation of cocaine in maternal and fetal hair; the dose response curve. Life Sci. 1992;50:1333-1341.
42. Pepin G, Gaillard Y. Concordance between self-reported drug use and findings in hair about cocaine and heroin. Forensic Sci Int. 1997;84:37-41.
43. Girod C, Staub C. Methadone and EDDP in hair from human subjects following a maintenance program: results of a pilot study. Forensic Sci Int. 2001:117:175-184.
44. Marquet P, Lavignasse P, Chevrel J, et al. Exposition au Subutex® in utero et syndrome de manque du nouveau-né. Toxicorama. 1999;11:17-24.
45. Wang EC. Methadone treatment during pregnancy. J Obstet Gynecol Neonatal Nurs. 1999;28(6):615-622.
46. Marquet P, Chevrel J, Lavignasse P, et al. Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Ther. 1997;62:569-571.